Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs VKA in NVAF Catheter Ablation
NCT01729871Phase 3Completed
- Sponsor
- Janssen Scientific Affairs
- Start
- Feb 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by Janssen Scientific Affairs. Started Feb 2013; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01729871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729871.